Ulla M. Kautto-Wartiovaara

Helsinki, Finland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

Real-world effectiveness and safety of blinatumomab in adults with B-cell precursor acute lymphoblastic leukaemia across 13 European countries.

Real-world effectiveness and safety of blinatumomab in adults with B-cell precursor acute lymphoblastic leukaemia across 13 European countries.

Journal: Blood cancer journal

Published: December 19, 2025

Distinct stem cell identities converge into shared erythroid stress in ERCC6L2 disease and Shwachman-Diamond syndrome.

Distinct stem cell identities converge into shared erythroid stress in ERCC6L2 disease and Shwachman-Diamond syndrome.

Journal: HemaSphere

Published: December 17, 2025

Late Diagnosis of NBEAL2-related Gray Platelet Syndrome in Finnish Siblings with Lifelong Thrombocytopenia.

Late Diagnosis of NBEAL2-related Gray Platelet Syndrome in Finnish Siblings with Lifelong Thrombocytopenia.

Journal: Hamostaseologie

Published: October 15, 2025

Blood donor biobank pipeline to collect genome-based samples for research.

Blood donor biobank pipeline to collect genome-based samples for research.

Journal: Scientific reports

Published: October 08, 2025

Allogeneic Hematopoietic Stem Cell Transplantation in ERCC6L2 Disease.

Allogeneic Hematopoietic Stem Cell Transplantation in ERCC6L2 Disease.

Journal: Blood advances

Published: September 09, 2025

Allogeneic hematopoietic stem cell transplantation in ERCC6L2 disease.

Allogeneic hematopoietic stem cell transplantation in ERCC6L2 disease.

Journal: Blood advances

Published: September 09, 2025

Intensive chemotherapy for high-risk acute lymphoblastic leukemia in first remission: results from the NOPHO ALL2008 study.

Intensive chemotherapy for high-risk acute lymphoblastic leukemia in first remission: results from the NOPHO ALL2008 study.

Journal: Leukemia

Published: May 15, 2025

Impact of CHEK2 germline variants on haematological malignancy risk and outcomes of allogeneic HSCT.

Impact of CHEK2 germline variants on haematological malignancy risk and outcomes of allogeneic HSCT.

Journal: British journal of haematology

Published: January 20, 2025

Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22+ Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia.

Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22+ Philadelphia Chromosome-Negative B-Cell Precursor Acute Lymphoblastic Leukemia.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 17, 2024

Impact of age and sex on survival outcomes in patients aged 1-45 years with acute lymphoblastic leukemia treated according to the stratification used in the NOPHO ALL2008 trial.

Impact of age and sex on survival outcomes in patients aged 1-45 years with acute lymphoblastic leukemia treated according to the stratification used in the NOPHO ALL2008 trial.

Journal: Haematologica

Published: June 15, 2024

How to manage patients with germline DDX41 variants: Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms.

How to manage patients with germline DDX41 variants: Recommendations from the Nordic working group on germline predisposition for myeloid neoplasms.

Journal: HemaSphere

Published: February 17, 2024

Biallelic hexokinase 1 (HK1) variants causative of non-spherocytic haemolytic anaemia: A case series with emphasis on the HK1 promoter variant and literature review.

Biallelic hexokinase 1 (HK1) variants causative of non-spherocytic haemolytic anaemia: A case series with emphasis on the HK1 promoter variant and literature review.

Journal: British journal of haematology

Published: November 18, 2023

Showing 1-12 of 42

Last Updated: 09/26/2026